Hypercalcemia as a biomarker of myeloproliferative neoplasms?

Authors

  • Stephen E. Langabeer Cancer Molecular Diagnostics, St. James’s Hospital, Dublin, Ireland Phone: +353-1-4103576, Fax: +353-1-4103513, E-mail: slangabeer@stjames.ie

DOI:

https://doi.org/10.17179/excli2019-1765

Keywords:

hypercalcemia, myeloproliferative neoplasms, molecular diagnostics

Published

2019-09-03

How to Cite

Langabeer, S. E. (2019). Hypercalcemia as a biomarker of myeloproliferative neoplasms?. EXCLI Journal, 18, 777–778. https://doi.org/10.17179/excli2019-1765

Issue

Section

Letters to the editor